Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Reprocessed Medical Device Bill May Have Smoother Sailing

This article was originally published in The Gray Sheet

Executive Summary

Bipartisan support could help facilitate the progress of reprocessed single-use medical device legislation pending in the House during the next congressional session, Hill staffers predict.

You may also be interested in...



Reprocessors, OEMs Will Operate On "Level Playing Field," Feigal Testifies

FDA Center for Devices and Radiological Health Director David Feigal promised the House Commerce/ Oversight and Investigations Subcommittee Feb. 10 that new regulations on reuse of single-use devices will be equally applied to manufacturers and reprocessors.

Reprocessors, OEMs Will Operate On "Level Playing Field," Feigal Testifies

FDA Center for Devices and Radiological Health Director David Feigal promised the House Commerce/ Oversight and Investigations Subcommittee Feb. 10 that new regulations on reuse of single-use devices will be equally applied to manufacturers and reprocessors.

Reuse of single use devices

FDA's proposed strategy for regulating reuse of single use medical devices "would continue to ignore the [Food, Drug and Cosmetic Act] and leave patients at risk," the Association of Disposable Device Manufacturers maintains in a Nov. 19 letter to Rep. Fred Upton (R-Mich.). The association expresses support for H.R. 3148, introduced Oct. 26 by Anna Eshoo (D-Calif.) and Upton (1"The Gray Sheet, Nov. 1, p. 6), which "will motivate the FDA to protect U.S. patients from reprocessed single use devices"

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel